Document Detail


Antinociceptive and Anti-Inflammatory Activities of the Ethanolic Extract, Fractions and 8-Methoxylapachenol from Sinningia allagophylla Tubers.
MedLine Citation:
PMID:  23336113     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
This study investigated the antinociceptive and anti-inflammatory activities of the ethanolic extract (EESAl), fractions and the compound 8-methoxylapachenol (8ML) obtained from the tubers of Sinningia allagophylla. Male Swiss mice were treated with EESAl (3-300 mg/kg) or vehicle by oral route (p.o.) 1 hr before the injection of formalin 2.5% or carrageenan (Cg) into the hind paw. EESAl (3-30 mg/kg) reduced the inflammatory phase of the nociceptive behaviour induced by formalin (around 65% for all doses). EESAl (3-300 mg/kg, p.o.) also reduced Cg-induced mechanical hyperalgesia and oedema in a dose-dependent fashion but did not change the hot-plate latency or the motor performance of the animals. Oral administration of petroleum ether fraction (PE, 3 mg/kg), but not in the methanolic fraction (30 mg/kg), reduced both Cg-induced oedema and hyperalgesia. Compound 8ML isolated from PE (1.8 mg/kg, p.o.) abolished Cg-induced hyperalgesia but also did not change hot-plate latency or motor performance of the animals. 8ML administration into the paw (0.75 - 750 pg) dose-dependently reduced Cg-induced hyperalgesia. 8ML (750pg) also blocked the hyperalgesia induced by tumour necrosis factor (TNF-α), interleukin-1β (IL-1β) and prostaglandin E(2) (PGE(2) ) but failed to change the hyperalgesia induced by cytokine-induced neutrophil chemoattractant-1 (CINC-1) and dopamine (Dopa). These results suggest that EESAl has an important antinociceptive and anti-inflammatory activity, the former one related, at least in part, to the reduction of the hyperalgesia. Similarly, 8ML reduced Cg-induced oedema and mechanical hyperalgesia and seems to act in peripheral sites and on the prostaglandin rather than on the sympathetic component of the Cg-inflammatory hyperalgesia.
Authors:
Felipe L Barbosa; Lídia S Mori; Dilamara Riva; Maria Élida A Stefanello; Aleksander R Zampronio
Related Documents :
22232773 - Mammography dosimetry using an in-house developed polymethyl methacrylate phantom.
9858413 - Determination of skin concentrations of enrofloxacin in dogs with pyoderma.
10496373 - Safety evaluation of ferrous bisglycinate chelate.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-22
Journal Detail:
Title:  Basic & clinical pharmacology & toxicology     Volume:  -     ISSN:  1742-7843     ISO Abbreviation:  Basic Clin. Pharmacol. Toxicol.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101208422     Medline TA:  Basic Clin Pharmacol Toxicol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2013 The Authors Basic & Clinical Pharmacology & Toxicology © 2013 Nordic Pharmacological Society.
Affiliation:
Department of Pharmacology, Federal University of Paraná, Curitiba, PR, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Surfactant-free (mini)emulsion polymerization of n-BA/S stabilized by NaMMT: Films with improved wat...
Next Document:  Milestones in the development of Nordic general practice*